Delivery Order SPE2DR25D1017-SPE2DR26F9BKD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for OxyContin ER 10 mg tablets (100-count units) with a contract value of $1,613.41. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a small-value pharmaceutical supply transaction executed under a competitive, non-set-aside procurement process. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $1,955.66, is set to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis, indicating open competitive procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a contract ceiling value of $1,824.59. This is a firm fixed-price delivery order with an ultimate completion date of May 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of OxyContin ER 20 mg tablets (100-count) valued at $2,416.56. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a single transaction under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.52 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract is classified as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units) with a ceiling value of $1,447.96. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) with a ceiling value of $1,871.50. The contract, which is not set-aside, was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania under firm fixed-price terms. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of OxyContin ER 30 mg tablets in quantities of 100 units, with a ceiling value of $1,045.05. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,766.17. This firm fixed-price, non-set-aside delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BKDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,408.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the Defense Health Agency and other federal healthcare systems by providing a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare programs worldwide. AmerisourceBergen's extensive federal procurement portfolio demonstrates consistent capability in delivering both brand-name and generic medications across multiple therapeutic domains through competitively awarded, firm fixed-price contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/14/25 |